CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease

Suzuki Yosuke; Fujioka Takashi; Sato Fuminori; Matsumoto Kunihiro; Muraya Nanako; Tanaka Ryota; Sato Yuhki; Ohno Keiko; Mimata Hiromitsu; Kishino Satoshi; Itoh Hiroki

首页> 外文期刊>British Journal of Clinical Pharmacology >CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease

【24h】

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease

机译：CYP3A5基因多态性影响终末期肾脏疾病患者活肾移植后CYP3A活性的增加

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIMS

机译：AIMS

著录项

来源
《British Journal of Clinical Pharmacology》 |2015年第6期|共8页
作者
Suzuki Yosuke; Fujioka Takashi; Sato Fuminori; Matsumoto Kunihiro; Muraya Nanako; Tanaka Ryota; Sato Yuhki; Ohno Keiko; Mimata Hiromitsu; Kishino Satoshi; Itoh Hiroki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
4 beta-hydroxycholesterol; CYP3A activity; CYP3A5 polymorphism; kidney transplantation;

机译：4β-羟基胆固醇;CYP3A活性;CYP3A5多态性;肾脏移植;
入库时间 2022-08-18 09:14:21

相似文献

外文文献
中文文献
专利

1. CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease [J] . Suzuki Yosuke, Fujioka Takashi, Sato Fuminori, British Journal of Clinical Pharmacology . 2015,第6期

机译：CYP3A5基因多态性影响终末期肾脏疾病患者活肾移植后CYP3A活性的增加
2. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem. [J] . Wang Y, Wang C, Li J, European journal of clinical pharmacology . 2009,第3期

机译：CYP3A5和MDR1基因多态性对地尔硫卓联合治疗的中国患者肾移植早期环孢素浓度的影响。
3. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem [J] . Yixi Wang, Changxi Wang, Jiali Li, European Journal of Clinical Pharmacology . 2009,第3期

机译：CYP3A5和MDR1基因多态性对地尔硫卓联合肾移植患者肾移植早期环孢素浓度的影响
4. Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients [C] . NIE Xin-min, GUI Rong, ZHAO Hong-shan, Postdoctoral Symposium for Celebration of 20th Anniversary of the Foundation of Chinese Postdoctoral System; 2005; . 2005

机译：CYP3A5基因多态性对肾移植患者他克莫司血药浓度的影响
5. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
6. CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease [O] . Yosuke Suzuki, Takashi Fujioka, Fuminori Sato, 2015

机译：CYP3A5基因多态性影响终末期肾脏疾病患者活肾移植后CYP3A活性的增加
7. Influence of Cytochrome P450 (CYP) 3A4*1G Polymorphism on the Pharmacokinetics of Tacrolimus, Probability of Acute Cellular Rejection, and mRNA Expression Level of CYP3A5 Rather than CYP3A4 in Living-Donor Liver Transplant Patients [O] . Miwa Uesugi, Mio Hosokawa, Haruka Shinke, 2013

机译：细胞色素P450（CYP） 3a4 * 1g对诱导肝脏移植患者的CYP3A5的急性细胞排斥，急性细胞排斥，急性细胞排斥的概率和MRNA表达水平的影响

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease

摘要

著录项

相似文献

相关主题

期刊订阅